Hello,
Today in
Digital health salaries revealed: How much 23andMe, GoodRx, Verily and 9 other health-tech upstarts pay their workers, from data scientists to software engineers
- Business Insider's analysis shows that many
digital health companies, like Teladoc and Verily, hire employees in the US at salaries ranging from around $64,000 to mid-six-figures. - Our analysis includes salaries for positions from scientists to data analysts. The roles we analyzed include: science, data, engineering, and more.
- The results come from a US Department of Labor database of base salaries for permanent and temporary foreign workers.
- While a limited sample, the data brings some level of salary transparency to the highly competitive digital health industry.
Read the full story from Megan Hernbroth and Maddy Simpson here>>
Pfizer's coronavirus vaccine requires 2 shots given 3 weeks apart, which could make distribution more complicated
Pfizer said on Monday that itscoronavirus vaccine candidate was found to be more than 90% effective in preventing COVID-19 in clinical trials.- The vaccine involves two shots administered three weeks apart.
- People may need additional booster shots too, experts say.
Read the full story from Aylin Woodward here>>
The US could be on track to hit 1 million daily coronavirus cases by the end of 2020, a new report finds
- The US could see 1 million daily coronavirus cases by the end of 2020, according to a new report from Pantheon Macroeconomics.
- That's based on the current trend of average cases rising 34% from week to week.
- Experts predict this surge could be the largest, and perhaps deadliest, yet.
Read the full story from Aria Bendix here>>
More stories we're reading:
- Meet the husband and wife team behind the leading coronavirus vaccine (The New York Times)
- As the holiday season approaches, New York Gov. Cuomo prohibits gatherings larger than 10 people at private residences (Business Insider)
- The CDC issued new advice saying cloth masks protect the wearer from COVID-19 infection. It's not that simple. (Business Insider)
- Moderna's analyzing its vaccine data ahead of releasing the results (Reuters)
See you tomorrow for a recap of this big week in healthcare news. Subscribe here in the meantime if you haven't yet!
- Lydia